Orgenesis Inc.
Cell populations, methods of transdifferentiation and methods of use thereof

Last updated:

Abstract:

The present invention provides methods for the sequential and temporally-regulated administration of pancreatic transcription factors to induce non-pancreatic cells to transdifferentiate and mature along the pancreatic .beta.-cell lineage. The present invention also provides methods for identifying, isolating and enriching transdifferentiation predisposed cells and methods for treating a degenerative pancreatic disorder such as diabetes.

Status:
Grant
Type:

Utility

Filling date:

25 Apr 2018

Issue date:

16 Mar 2021